Northern Trust Company of Connecticut’s Halozyme HALO Stock Holding History

Northern Trust Company of Connecticut’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$22K	Buy	+1,450	New	+$18.6K	﹤0.01%	1983

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Company of Connecticut's HALO Position: Q4 2013 in Review

Northern Trust Company of Connecticut opened a new position in Halozyme (HALO) in Q4 2013: 1,450 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #1983 among its holdings.

119 funds tracked by Wall St. Rank hold HALO as of Q4 2013.

Northern Trust Company of Connecticut held 1,450 shares of Halozyme worth $22K as of Q4 2013.
Halozyme was a new Northern Trust Company of Connecticut position in Q4 2013.
Halozyme made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1983 holding.
119 funds tracked by Wall St. Rank held Halozyme as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.